Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial

<p><strong>Background</strong></p> Immunosuppressive treatments inhibit vaccine-induced immunity against SARS-CoV-2. We evaluated whether a 2-week interruption of methotrexate treatment immediately after the COVID-19 vaccine booster improved antibody responses against the S1...

সম্পূর্ণ বিবরণ

গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক:	Abhishek, A, Boyton, RJ, Peckham, N, McKnight, Á, Coates, LC, Bluett, J, Barber, V, Cureton, L, Francis, A, Appelbe, D, Eldridge, L, Julier, P, Valdes, AM, Brooks, T, Rombach, I, Altmann, DM, Nguyen-Van-Tam, JS, Williams, HC, Cook, JA
অন্যান্য লেখক:	VROOM study investigators
বিন্যাস:	Journal article
ভাষা:	English
প্রকাশিত:	Elsevier 2022

Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a ra... অনুযায়ী Abhishek, A, Boyton, RJ, Peckham, N, McKnight, Á, Coates, LC, Bluett, J, Barber, V, Cureton, L, Francis, A, Appelbe, D, Eldridge, L, Julier, P, Valdes, AM, Brooks, T, Rombach, I, Altmann, DM, Nguyen-Van-Tam, JS, Williams, HC, Cook, JA

প্রকাশিত 2022

Journal article

Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial

অনুরূপ উপাদানগুলি